CVS Health Corporation (NYSE:CVS) Sees Significant Drop in Short Interest

CVS Health Corporation (NYSE:CVS) saw a significant decrease in short interest in the month of February. As of February 13th, there was short interest totaling 16,528,176 shares, a decrease of 18.8% from the January 29th total of 20,354,623 shares. Approximately 1.3% of the shares of the company are short sold. Based on an average daily volume of 9,397,283 shares, the short-interest ratio is presently 1.8 days. Based on an average daily volume of 9,397,283 shares, the short-interest ratio is presently 1.8 days. Approximately 1.3% of the shares of the company are short sold.

CVS Health Stock Performance

Shares of CVS traded down $1.25 during trading hours on Tuesday, reaching $80.41. 7,090,002 shares of the company’s stock traded hands, compared to its average volume of 9,520,307. CVS Health has a twelve month low of $58.35 and a twelve month high of $85.15. The business’s fifty day simple moving average is $78.46 and its two-hundred day simple moving average is $77.39. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The firm has a market capitalization of $102.30 billion, a price-to-earnings ratio of 58.27, a P/E/G ratio of 0.83 and a beta of 0.49.

CVS Health (NYSE:CVS) last announced its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s revenue was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts predict that CVS Health will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is 192.75%.

Institutional Trading of CVS Health

Several institutional investors have recently modified their holdings of CVS. S Harris Financial Group LLC acquired a new position in CVS Health during the fourth quarter worth about $204,000. Reflection Asset Management bought a new position in shares of CVS Health during the 4th quarter valued at about $98,000. Sankala Group LLC bought a new stake in shares of CVS Health in the 4th quarter worth approximately $28,000. TD Capital Management LLC lifted its stake in CVS Health by 67.4% during the fourth quarter. TD Capital Management LLC now owns 698 shares of the pharmacy operator’s stock valued at $55,000 after purchasing an additional 281 shares during the last quarter. Finally, MidFirst Bank bought a new stake in CVS Health during the fourth quarter worth approximately $278,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. TD Cowen increased their price objective on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. UBS Group reiterated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Argus reduced their price objective on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. JPMorgan Chase & Co. increased their target price on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Finally, Morgan Stanley boosted their price target on shares of CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Nineteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average target price of $94.77.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.